Cargando…
SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
One year into the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic, the 2020 San Antonio Breast Cancer Symposium (SABCS) was another large congress held in a virtual format. Despite these circumstances, clinically relevant data were presented, and this short review focuses...
Autor principal: | Bartsch, Rupert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240615/ https://www.ncbi.nlm.nih.gov/pubmed/34221179 http://dx.doi.org/10.1007/s12254-021-00722-4 |
Ejemplares similares
-
SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy
por: Bartsch, Rupert, et al.
Publicado: (2018) -
SABCS 2016: systemic therapy for metastatic breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2017) -
ASCO 2018: highlights in HER2-positive metastatic breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2018) -
Post SABCS local therapy and radiology
por: Fitzal, Florian
Publicado: (2018) -
SABCS 2017 pathology: from bench to bedside
por: Bago-Horvath, Zsuzsanna
Publicado: (2018)